TOKYO -- Researchers from Japan's Keio University and elsewhere announced Thursday that they have begun a clinical trial on a gene therapy to restore light sensitivity in patients with retinitis pigmentosa, a hereditary eye disorder.
Science
Japan researchers target degenerative eye disease with gene therapy
Keio University-linked startup launches clinical trials of retina treatment
Toshihide Kurihara, associate professor of ophthalmology at Keio University, speaks on Feb. 13 about the start of clinical trials. (Photo by Noriaki Koshikawa)
Read Next
Latest on Science
